Vital Chemtech Limited (NSE:VITAL)
India · Delayed Price · Currency is INR 50.50
-1.13 (-2.19%)
Nov 12, 2026, 2:57 PM IST
Vital Chemtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,631 | 1,264 | 1,339 | 982.74 | 1,167 | 576.15 |
Other Revenue | 6.39 | - | - | - | 0 | -0 |
| 1,637 | 1,264 | 1,339 | 982.74 | 1,167 | 576.15 | |
Revenue Growth | 23.51% | -5.57% | 36.26% | -15.82% | 102.63% | 21.54% |
Cost of Revenue | 1,226 | 980.44 | 1,065 | 759.46 | 859.89 | 391.87 |
Gross Profit | 411.21 | 283.98 | 274.02 | 223.28 | 307.55 | 184.28 |
Selling, General & Admin | 109.2 | 79.45 | 61.94 | 36.86 | 29.36 | 19.12 |
Other Operating Expenses | 134.75 | 100.65 | 104.9 | 187.09 | 128.63 | 49.21 |
Operating Expenses | 317.06 | 240.05 | 216.58 | 250.29 | 181.17 | 75.29 |
Operating Income | 94.15 | 43.93 | 57.43 | -27.01 | 126.38 | 108.99 |
Interest Expense | -37.31 | -24.81 | -19.7 | -6.78 | -5.7 | -1.69 |
Interest & Investment Income | 8.04 | 8.04 | 17.41 | 23.46 | 7.28 | 0.53 |
Currency Exchange Gain (Loss) | -2.81 | -2.81 | 2.26 | 7.41 | -7.48 | 1.31 |
Other Non Operating Income (Expenses) | -6.65 | -6.65 | -1.84 | -5.69 | -5.53 | -3.15 |
EBT Excluding Unusual Items | 55.41 | 17.7 | 55.57 | -8.61 | 114.95 | 105.98 |
Gain (Loss) on Sale of Investments | 3.02 | 3.02 | 4.34 | 4.95 | - | - |
Gain (Loss) on Sale of Assets | 0.15 | 0.15 | - | 0.13 | -0.1 | - |
Pretax Income | 58.58 | 20.87 | 59.91 | -3.53 | 114.85 | 105.98 |
Income Tax Expense | 10.12 | 10.6 | 20.22 | 9.5 | 34.33 | 27 |
Net Income | 48.47 | 10.27 | 39.69 | -13.02 | 80.51 | 78.98 |
Net Income to Common | 48.47 | 10.27 | 39.69 | -13.02 | 80.51 | 78.98 |
Net Income Growth | 56.50% | -74.13% | - | - | 1.94% | 168.85% |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 18 | 7 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 18 | 7 |
Shares Change | -1.27% | - | 0.77% | 33.87% | 166.18% | -39.99% |
EPS (Basic) | 2.01 | 0.43 | 1.66 | -0.54 | 4.50 | 11.75 |
EPS (Diluted) | 2.00 | 0.43 | 1.66 | -0.54 | 4.50 | 11.75 |
EPS Growth | 58.87% | -74.13% | - | - | -61.70% | 348.47% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -80.56 | -186.05 | -398.6 | -68.25 | -178.22 | -219.24 |
Free Cash Flow Per Share | -3.32 | -7.71 | -16.52 | -2.85 | -9.96 | -32.62 |
Dividend Per Share | - | - | - | 0.500 | 0.500 | - |
Dividend Growth | - | - | - | 0% | - | - |
Gross Margin | 25.12% | 22.46% | 20.46% | 22.72% | 26.34% | 31.99% |
Operating Margin | 5.75% | 3.48% | 4.29% | -2.75% | 10.82% | 18.92% |
Profit Margin | 2.96% | 0.81% | 2.96% | -1.32% | 6.90% | 13.71% |
Free Cash Flow Margin | -4.92% | -14.71% | -29.77% | -6.94% | -15.27% | -38.05% |
EBITDA | 167.26 | 103.88 | 107.18 | -0.68 | 149.55 | 115.95 |
EBITDA Margin | 10.22% | 8.21% | 8.00% | -0.07% | 12.81% | 20.13% |
D&A For EBITDA | 73.12 | 59.94 | 49.75 | 26.33 | 23.18 | 6.96 |
EBIT | 94.15 | 43.93 | 57.43 | -27.01 | 126.38 | 108.99 |
EBIT Margin | 5.75% | 3.48% | 4.29% | -2.75% | 10.82% | 18.92% |
Effective Tax Rate | 17.27% | 50.80% | 33.75% | - | 29.89% | 25.48% |
Revenue as Reported | 1,649 | 1,276 | 1,364 | 1,016 | 1,169 | 578.7 |
Advertising Expenses | - | 2.15 | 1.05 | - | 0.92 | 5.93 |